Chronic obstructive pulmonary disease and respiratory failure
https://doi.org/10.4081/gc.2023.11476
Accepted: 4 December 2023
HTML: 12
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Chronic obstructive pulmonary disease is a current problem for elderly patients due to diffusion, mortality, and other negative outcomes. The most complex management aspects consist of the presence of frailty, which increases the risk of complications and adverse drug events and reduces the effectiveness of treatments. In this context, to determine the best individualized treatment, it is crucial to have an excellent understanding of the medical and non-medical treatments available, the use of ventilation systems, combined with in-depth geriatric knowledge.
Fried TR, Vaz Fragoso CA, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease: “I was worried that he didn’t have much room to decline”. JAMA 2012;308:10.1001/jama.2012.12422. DOI: https://doi.org/10.1001/jama.2012.12422
Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med 2022;10:447-58. DOI: https://doi.org/10.1016/S2213-2600(21)00511-7
Rojas M, Mora AL, Kapetanaki M, et al. Aging and lung disease. clinical impact and cellular and molecular pathways. Ann Am Thorac Soc 2015;12:S222-7. DOI: https://doi.org/10.1513/AnnalsATS.201508-484PL
Cortopassi F, Gurung P, Pinto-Plata V. Chronic obstructive pulmonary disease in elderly patients. Clin Geriatr Med 2017;33:539-52. DOI: https://doi.org/10.1016/j.cger.2017.06.006
López-Campos JL, Quintana Gallego E, et al. Status of and strategies for improving adherence to COPD treatment. Int J Chron Obstruct Pulmon Dis 2019;14:1503-15. DOI: https://doi.org/10.2147/COPD.S170848
Verschoor CP, Cakmak S, Lukina AO, Dales RE. Activity-related dyspnea in older adults participating in the Canadian Longitudinal Study on Aging. J Gen Intern Med 2022;37:3302-9. DOI: https://doi.org/10.1007/s11606-021-07374-4
Akgün KM, Krishnan S, Feder SL, et al. Polypharmacy increases risk of dyspnea among adults with serious, life-limiting diseases. Am J Hosp Palliat Care 2020;37:278-85. DOI: https://doi.org/10.1177/1049909119877512
Benz E, Trajanoska K, Lahousse L, et al. Sarcopenia in COPD: a systematic review and meta-analysis. Eur Respir Rev 2019;28:190049. DOI: https://doi.org/10.1183/16000617.0049-2019
Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging 2006;1:253-60. DOI: https://doi.org/10.2147/ciia.2006.1.3.253
Singh D. Blood eosinophil counts in chronic obstructive pulmonary disease: a biomarker of inhaled corticosteroid effects. Tuberc Respir Dis (Seoul) 2020;83:185-94. DOI: https://doi.org/10.4046/trd.2020.0026
Fu Y, Chapman EJ, Boland AC, Bennett MI. Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): a practice review. Palliat Med 2022;36:770-82. DOI: https://doi.org/10.1177/02692163221079697
Wei T, Wang X, Lang K, et al. Low eosinophil phenotype predicts noninvasive mechanical ventilation use in patients with hospitalized exacerbations of COPD. J Inflamm Res 2022;15:1259-71. Erratum in: J Inflamm Res 2022;15:1993-4. DOI: https://doi.org/10.2147/JIR.S343918
Singh S, Loke YK, Enright P, Furberg CD. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax 2013;68:114-6. DOI: https://doi.org/10.1136/thoraxjnl-2011-201275
Loke YK, Singh S. Risk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review. Ther Adv Drug Saf 2013;4:19-26. DOI: https://doi.org/10.1177/2042098612472928
Masror-Roudsary D, Fadaee Aghdam N, Rafii F, et al. The relationship between experienced respiratory symptoms and health-related quality of life in the elderly with chronic obstructive pulmonary disease. Crit Care Res Pract 2021;2021:5564275. DOI: https://doi.org/10.1155/2021/5564275
Matera MG, Cazzola M, Page C. Prospects for COPD treatment. Curr Opin Pharmacol 2021;56:74-84. DOI: https://doi.org/10.1016/j.coph.2020.11.003
Suissa S, Dell'Aniello S, Ernst P. Triple inhaler versus dual bronchodilator therapy in COPD: real-world effectiveness on mortality. COPD 2022;19:1-9. DOI: https://doi.org/10.1080/15412555.2021.1977789
Li W, Pu Y, Meng A, et al. Effectiveness of pulmonary rehabilitation in elderly patients with COPD: a systematic review and meta-analysis of randomized controlled trials. Int J Nurs Pract 2019;25:e12745. DOI: https://doi.org/10.1111/ijn.12745
Echevarria C, Steer J, Wason J, Bourke S. Oxygen therapy and inpatient mortality in COPD exacerbation. Emerg Med J 2021;38:170-7. DOI: https://doi.org/10.1136/emermed-2019-209257
Tønnesen P. Smoking cessation and COPD. Eur Respir Rev 2013;22:37-43. DOI: https://doi.org/10.1183/09059180.00007212
Joean O, Welte T. Vaccination and modern management of chronic obstructive pulmonary disease - a narrative review. Expert Rev Respir Med 2022;16:605-14. DOI: https://doi.org/10.1080/17476348.2022.2092099
Hanlon P, Lewsey J, Quint JK, et al. Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank. BMJ Open Resp Res 2022;9:e001314. DOI: https://doi.org/10.1136/bmjresp-2022-001314
Kowalczyk A, Kosiek K, Godycki-Cwirko M, Zakowska I. Community determinants of COPD exacerbations in elderly patients in Lodz province, Poland: a retrospective observational Big Data cohort study. BMJ Open 2022;12:e060247. DOI: https://doi.org/10.1136/bmjopen-2021-060247
Csoma B, Vulpi MR, Dragonieri S, et al Hypercapnia in COPD: causes, consequences, and therapy. J Clin Med 2022;11:3180. DOI: https://doi.org/10.3390/jcm11113180
Custodero C, Gandolfo F, Cella A, et al. Multidimensional prognostic index (MPI) predicts non-invasive ventilation failure in older adults with acute respiratory failure. Arch Gerontol Geriatr 2021;94:104327. DOI: https://doi.org/10.1016/j.archger.2020.104327
Pilotto A, Topinkova E, Michalkova H, et al. Can the multidimensional prognostic index improve the identification of older hospitalized patients with COVID-19 likely to benefit from mechanical ventilation? An observational, prospective, multicenter study. J Am Med Dir Assoc 2022;23:1608.e1-1608.e8. DOI: https://doi.org/10.1016/j.jamda.2022.06.023
Spicuzza L, Schisano M. High-flow nasal cannula oxygen therapy as an emerging option for respiratory failure: the present and the future. Ther Adv Chronic Dis 2020;11:2040622320920106. DOI: https://doi.org/10.1177/2040622320920106
Carratalá JM, Diaz-Lobato S, Brouzet B, et al. Efficacy and safety of high-flow nasal cannula therapy in elderly patients with acute respiratory failure. Pulmonology 2023. doi: 10.1016/j.pulmoe.2023.01.004. DOI: https://doi.org/10.1016/j.pulmoe.2023.01.004
Oczkowski S, Ergan B, Bos L, et al. ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J 2022;59:2101574. DOI: https://doi.org/10.1183/13993003.01574-2021
Feng Z, Zhang L, Yu H, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for AECOPD patients after extubation: a systematic review and meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis 2022;17:1987-99. DOI: https://doi.org/10.2147/COPD.S375107
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
